COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 881: Articles 8801-8810  | Next

Co-infection with SARS-COV-2 Omicron and Delta Variants Revealed by Genomic Surveillance
Rockett, R. J., Draper, J., Gall, M., Sim, E. M., Arnott, A., Agius, J. E., Johnson-Mackinnon, J., Martinez, E., Drew, A. P., Lee, C., Ngo, C., Ramsperger, M., Ginn, A. N., Wang, Q., Fennell, M., Ko, D., Huston, L., Kairaitis, L., Holmes, E. C., O'Sullivan, M. N., Chen, S. C.-A., Kok, J., Dwyer, D. E., Sintchenko, V.
10.1101/2022.02.13.22270755 — Posted: 2022-02-15
Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
Lowe, D. M., Brown, L.-A. K., Chowdhury, K., Davey, S., Yee, P., Ikeji, F., Ndoutoumou, A., Shah, D., Lennon, A., Rai, A., Agyeman, A. A., Checkley, A., Longley, N., Dehbi, H.-M., Freemantle, N., Breuer, J., Standing, J. F., FLARE Investigators
10.1101/2022.02.11.22270775 — Posted: 2022-02-15
Users' Reactions on Announced Vaccines against COVID-19 Before Marketing in France: Analysis of Twitter posts
Dupuy-Zini, A., Audeh, B., Gagneux-Brunon, A., Bousquet, C.
10.1101/2022.02.14.22268832 — Posted: 2022-02-15
Diagnostic Accuracy of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era
Bernstein, D. I., Mejias, A., Rath, B., Woods, C. W., Philips Deeter, J.
10.1101/2022.02.14.22270927 — Posted: 2022-02-15
Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020-April 2021
Lee, W.-E., Woo Park, S., Wienberger, D. M., Olson, D., Simonsen, L., Grenfell, B. T., Viboud, C.
10.1101/2022.02.10.22270721 — Posted: 2022-02-15
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, July 2020 to June 2021-a follow-up
Fischer, B., Vollmer, T., Knabbe, C.
10.1101/2022.02.11.22270833 — Posted: 2022-02-15
Source terms for benchmarking models of SARS-CoV-2 transmission via aerosols and droplets
Stettler, M. E. J., Nishida, R. T., de Oliveira, P. M., Mesquita, L., Johnson, T., Galea, E., Grandison, A., Ewer, J., Carruthers, D., Kumar, P., Avital, E., Obeysekara, A., Doorly, D., Hardalupas, Y., Green, D., Coldrick, S., Parker, S., Boies, A.
10.1101/2022.02.11.22270844 — Posted: 2022-02-15
Demographic Characteristics and Clinical Features of COVID-19 Patients Admitted in a Combined Military Hospital of Bangladesh
Mahboob, S., Johora, F., Abbasy, A. A., Jeenia, F. T., Ali, M., Naharin, N. E., Ferdoush, J.
10.1101/2022.02.12.22270893 — Posted: 2022-02-15
Structural risk factors for SARS-CoV-2 infection in an urban slum: Age, gender and income
Fofana, M. O., Nery, N., Aguilar Ticona, P. P., Andrade Belitardo, E. M. M., Victoriano, R., Anjos, R. O., Portilho, M. M., de Santana, M. C., dos Santos, L. L., de Oliveira, D., Cruz, J. S., Muencker, M. C., Khouri, R., Wunder, E., Hitchings, M., Johnson, O., Reis, M. G., Riberiro, G. S., Cummings, D. A. T., Costa, F., Ko, A. I.
10.1101/2022.02.13.22270856 — Posted: 2022-02-15
Differential durability of humoral and T cell immunity after two and three BNT162b2 vaccinations in adults aged >80 years
Romero Olmedo, A. J., Schulz, A. R., Hochstaetter, S., Das Gupta, D., Hirseland, H., Staudenraus, D., Camara, B., Volland, K., Hefter, V., Sapre, S., Kraehling, V., Mueller-Kraeuter, H., Mei, H., Keller, C., Lohoff, M.
10.1101/2022.02.10.22270733 — Posted: 2022-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).